Pneumococcal Vaccines Market Report

Europe Pneumococcal Vaccines Market Size, Status and Forecast 2014-2026

  • POSTDATE：Feb 17, 2020
  • PAGES：186
  • REPORT CODE：GMM475637
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Pneumococcal Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.1% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Pneumococcal Vaccines Market Segmentations:

    By Player:

    • GSK

    • Lupin

    • Valneva Austria

    • Genocea Biosciences

    • Eli Lilly

    • Biken

    • Sanofi

    • Genentech

    • Pfizer

    • S K Chemicals

    • ImmunoBiology

    • Celgene Corporation

    • Abera

    • Baxter

    • Biogen

    • AstraZeneca

    • Panacea Biotec

    • Merck

    • Sinovac

    • Serum Institute of India

    • Beijing Minhai Biotechnology

    • Nuron Biotech

    By Type:

    • PPSV 23

    • PCV 7/13

    • PCV 10

    By End-User:

    • For Infants

    • For Children (2-10)

    • For Person (10-64)

    • For

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pneumococcal Vaccines Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Pneumococcal Vaccines Market Size and Growth Rate of PPSV 23 from 2014 to 2026

    • 1.3.2 Europe Pneumococcal Vaccines Market Size and Growth Rate of PCV 7/13 from 2014 to 2026

    • 1.3.3 Europe Pneumococcal Vaccines Market Size and Growth Rate of PCV 10 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Pneumococcal Vaccines Market Size and Growth Rate of For Infants from 2014 to 2026

    • 1.4.2 Europe Pneumococcal Vaccines Market Size and Growth Rate of For Children (2-10) from 2014 to 2026

    • 1.4.3 Europe Pneumococcal Vaccines Market Size and Growth Rate of For Person (10-64) from 2014 to 2026

    • 1.4.4 Europe Pneumococcal Vaccines Market Size and Growth Rate of For from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Pneumococcal Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pneumococcal Vaccines by Major Types

      • 3.4.1 Market Size and Growth Rate of PPSV 23

      • 3.4.2 Market Size and Growth Rate of PCV 7/13

      • 3.4.3 Market Size and Growth Rate of PCV 10

    4 Segmentation of Pneumococcal Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pneumococcal Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pneumococcal Vaccines for For Infants

      • 4.4.2 Market Size and Growth Rate of Pneumococcal Vaccines for For Children (2-10)

      • 4.4.3 Market Size and Growth Rate of Pneumococcal Vaccines for For Person (10-64)

      • 4.4.4 Market Size and Growth Rate of Pneumococcal Vaccines for For

    5 Market Analysis by Major Regions

    • 5.1 Europe Pneumococcal Vaccines Production Analysis by Top Regions

    • 5.2 Europe Pneumococcal Vaccines Consumption Analysis by Top Regions

    • 5.3 Europe Pneumococcal Vaccines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.3 France Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    6 Product Circulation of Pneumococcal Vaccines Market among Top Countries

    • 6.1 Top 5 Export Countries in Pneumococcal Vaccines Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Pneumococcal Vaccines Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Pneumococcal Vaccines Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Pneumococcal Vaccines Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Pneumococcal Vaccines Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Pneumococcal Vaccines Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Pneumococcal Vaccines Landscape Analysis

    • 7.1 Germany Pneumococcal Vaccines Landscape Analysis by Major Types

    • 7.2 Germany Pneumococcal Vaccines Landscape Analysis by Major End-Users

    8. UK Pneumococcal Vaccines Landscape Analysis

    • 8.1 UK Pneumococcal Vaccines Landscape Analysis by Major Types

    • 8.2 UK Pneumococcal Vaccines Landscape Analysis by Major End-Users

    9. France Pneumococcal Vaccines Landscape Analysis

    • 9.1 France Pneumococcal Vaccines Landscape Analysis by Major Types

    • 9.2 France Pneumococcal Vaccines Landscape Analysis by Major End-Users

    10. Italy Pneumococcal Vaccines Landscape Analysis

    • 10.1 Italy Pneumococcal Vaccines Landscape Analysis by Major Types

    • 10.2 Italy Pneumococcal Vaccines Landscape Analysis by Major End-Users

    11. Spain Pneumococcal Vaccines Landscape Analysis

    • 11.1 Spain Pneumococcal Vaccines Landscape Analysis by Major Types

    • 11.2 Spain Pneumococcal Vaccines Landscape Analysis by Major End-Users

    12. Poland Pneumococcal Vaccines Landscape Analysis

    • 12.1 Poland Pneumococcal Vaccines Landscape Analysis by Major Types

    • 12.2 Poland Pneumococcal Vaccines Landscape Analysis by Major End-Users

    13. Russia Pneumococcal Vaccines Landscape Analysis

    • 13.1 Russia Pneumococcal Vaccines Landscape Analysis by Major Types

    • 13.2 Russia Pneumococcal Vaccines Landscape Analysis by Major End-Users

    14. Switzerland Pneumococcal Vaccines Landscape Analysis

    • 14.1 Switzerland Pneumococcal Vaccines Landscape Analysis by Major Types

    • 14.2 Switzerland Pneumococcal Vaccines Landscape Analysis by Major End-Users

    15. Turkey Pneumococcal Vaccines Landscape Analysis

    • 15.1 Turkey Pneumococcal Vaccines Landscape Analysis by Major Types

    • 15.2 Turkey Pneumococcal Vaccines Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Landscape Analysis by Top Countries

      • 16.3.1 Denmark Pneumococcal Vaccines Market Volume and Growth Rate

      • 16.3.2 Finland Pneumococcal Vaccines Market Volume and Growth Rate

      • 16.3.3 Norway Pneumococcal Vaccines Market Volume and Growth Rate

      • 16.3.4 Sweden Pneumococcal Vaccines Market Volume and Growth Rate

      • 16.3.6 Iceland Pneumococcal Vaccines Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Landscape Analysis by Top Countries

      • 17.3.1 Belgium Pneumococcal Vaccines Market Volume and Growth Rate

      • 17.3.2 Netherlands Pneumococcal Vaccines Market Volume and Growth Rate

      • 17.3.3 Luxembourg Pneumococcal Vaccines Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Landscape Analysis by Top Countries

      • 18.3.1 Estonia Pneumococcal Vaccines Market Volume and Growth Rate

      • 18.3.2 Latvia Pneumococcal Vaccines Market Volume and Growth Rate

      • 18.3.3 Lithuania Pneumococcal Vaccines Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 GSK

      • 19.1.1 GSK Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Lupin

      • 19.2.1 Lupin Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Valneva Austria

      • 19.3.1 Valneva Austria Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Genocea Biosciences

      • 19.4.1 Genocea Biosciences Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Eli Lilly

      • 19.5.1 Eli Lilly Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Biken

      • 19.6.1 Biken Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Sanofi

      • 19.7.1 Sanofi Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Genentech

      • 19.8.1 Genentech Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Pfizer

      • 19.9.1 Pfizer Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 S K Chemicals

      • 19.10.1 S K Chemicals Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 ImmunoBiology

      • 19.11.1 ImmunoBiology Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Celgene Corporation

      • 19.12.1 Celgene Corporation Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Abera

      • 19.13.1 Abera Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Baxter

      • 19.14.1 Baxter Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Biogen

      • 19.15.1 Biogen Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 AstraZeneca

      • 19.16.1 AstraZeneca Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Panacea Biotec

      • 19.17.1 Panacea Biotec Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Merck

      • 19.18.1 Merck Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Sinovac

      • 19.19.1 Sinovac Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Serum Institute of India

      • 19.20.1 Serum Institute of India Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Beijing Minhai Biotechnology

      • 19.21.1 Beijing Minhai Biotechnology Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Nuron Biotech

      • 19.22.1 Nuron Biotech Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    The List of Tables and Figures (Totals 79 Figures and 117 Tables)

    • Figure Product Picture

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of PPSV 23 from 2014 to 2026

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of PCV 7/13 from 2014 to 2026

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of PCV 10 from 2014 to 2026

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of For Infants from 2014 to 2026

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of For Children (2-10) from 2014 to 2026

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of For Person (10-64) from 2014 to 2026

    • Figure Europe Pneumococcal Vaccines Market Size and Growth Rate of For from 2014 to 2026

    • Figure Germany Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure UK Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure France Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Pneumococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pneumococcal Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pneumococcal Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pneumococcal Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Pneumococcal Vaccines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of PPSV 23

    • Figure Market Size and Growth Rate of PCV 7/13

    • Figure Market Size and Growth Rate of PCV 10

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pneumococcal Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pneumococcal Vaccines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of For Infants

    • Figure Market Size and Growth Rate of For Children (2-10)

    • Figure Market Size and Growth Rate of For Person (10-64)

    • Figure Market Size and Growth Rate of For

    • Table Europe Pneumococcal Vaccines Production by Major Regions

    • Table Europe Pneumococcal Vaccines Production Share by Major Regions

    • Figure Europe Pneumococcal Vaccines Production Share by Major Countries and Regions in 2014

    • Table Europe Pneumococcal Vaccines Consumption by Major Regions

    • Table Europe Pneumococcal Vaccines Consumption Share by Major Regions

    • Table Germany Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table UK Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table France Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Italy Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Spain Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Poland Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Russia Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Switzerland Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Turkey Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Pneumococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Pneumococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Pneumococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Pneumococcal Vaccines Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Germany Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Germany Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Germany Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table UK Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table UK Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table UK Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table UK Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table France Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table France Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table France Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table France Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Italy Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Italy Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Italy Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Italy Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Spain Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Spain Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Spain Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Spain Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Poland Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Poland Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Poland Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Poland Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Russia Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Russia Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Russia Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Russia Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Switzerland Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Switzerland Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Switzerland Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Turkey Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Turkey Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Turkey Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pneumococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pneumococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pneumococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Pneumococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Lupin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin

    • Figure Sales and Growth Rate Analysis of Lupin

    • Figure Revenue and Market Share Analysis of Lupin

    • Table Product and Service Introduction of Lupin

    • Table Company Profile and Development Status of Valneva Austria

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valneva Austria

    • Figure Sales and Growth Rate Analysis of Valneva Austria

    • Figure Revenue and Market Share Analysis of Valneva Austria

    • Table Product and Service Introduction of Valneva Austria

    • Table Company Profile and Development Status of Genocea Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genocea Biosciences

    • Figure Sales and Growth Rate Analysis of Genocea Biosciences

    • Figure Revenue and Market Share Analysis of Genocea Biosciences

    • Table Product and Service Introduction of Genocea Biosciences

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Biken

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biken

    • Figure Sales and Growth Rate Analysis of Biken

    • Figure Revenue and Market Share Analysis of Biken

    • Table Product and Service Introduction of Biken

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Genentech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech

    • Figure Sales and Growth Rate Analysis of Genentech

    • Figure Revenue and Market Share Analysis of Genentech

    • Table Product and Service Introduction of Genentech

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of S K Chemicals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of S K Chemicals

    • Figure Sales and Growth Rate Analysis of S K Chemicals

    • Figure Revenue and Market Share Analysis of S K Chemicals

    • Table Product and Service Introduction of S K Chemicals

    • Table Company Profile and Development Status of ImmunoBiology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ImmunoBiology

    • Figure Sales and Growth Rate Analysis of ImmunoBiology

    • Figure Revenue and Market Share Analysis of ImmunoBiology

    • Table Product and Service Introduction of ImmunoBiology

    • Table Company Profile and Development Status of Celgene Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation

    • Figure Sales and Growth Rate Analysis of Celgene Corporation

    • Figure Revenue and Market Share Analysis of Celgene Corporation

    • Table Product and Service Introduction of Celgene Corporation

    • Table Company Profile and Development Status of Abera

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abera

    • Figure Sales and Growth Rate Analysis of Abera

    • Figure Revenue and Market Share Analysis of Abera

    • Table Product and Service Introduction of Abera

    • Table Company Profile and Development Status of Baxter

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter

    • Figure Sales and Growth Rate Analysis of Baxter

    • Figure Revenue and Market Share Analysis of Baxter

    • Table Product and Service Introduction of Baxter

    • Table Company Profile and Development Status of Biogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen

    • Figure Sales and Growth Rate Analysis of Biogen

    • Figure Revenue and Market Share Analysis of Biogen

    • Table Product and Service Introduction of Biogen

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Panacea Biotec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Panacea Biotec

    • Figure Sales and Growth Rate Analysis of Panacea Biotec

    • Figure Revenue and Market Share Analysis of Panacea Biotec

    • Table Product and Service Introduction of Panacea Biotec

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Sinovac

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sinovac

    • Figure Sales and Growth Rate Analysis of Sinovac

    • Figure Revenue and Market Share Analysis of Sinovac

    • Table Product and Service Introduction of Sinovac

    • Table Company Profile and Development Status of Serum Institute of India

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute of India

    • Figure Sales and Growth Rate Analysis of Serum Institute of India

    • Figure Revenue and Market Share Analysis of Serum Institute of India

    • Table Product and Service Introduction of Serum Institute of India

    • Table Company Profile and Development Status of Beijing Minhai Biotechnology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beijing Minhai Biotechnology

    • Figure Sales and Growth Rate Analysis of Beijing Minhai Biotechnology

    • Figure Revenue and Market Share Analysis of Beijing Minhai Biotechnology

    • Table Product and Service Introduction of Beijing Minhai Biotechnology

    • Table Company Profile and Development Status of Nuron Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nuron Biotech

    • Figure Sales and Growth Rate Analysis of Nuron Biotech

    • Figure Revenue and Market Share Analysis of Nuron Biotech

    • Table Product and Service Introduction of Nuron Biotech

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US